- Previous Close
64.11 - Open
63.62 - Bid --
- Ask --
- Day's Range
62.28 - 64.00 - 52 Week Range
33.59 - 67.69 - Volume
359,059 - Avg. Volume
384,561 - Market Cap (intraday)
2.37B - Beta (5Y Monthly) 0.95
- PE Ratio (TTM)
23.70 - EPS (TTM)
2.66 - Earnings Date Aug 8, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Nov 30, 2016
- 1y Target Est
68.33
Adtalem Global Education Inc. provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University. The Walden segment offers online certificates, bachelor's, master's, and doctoral degrees, including nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. This segment also operates Walden University. The Medical and Veterinary segment provides degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment operates American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.
www.adtalem.com4,368
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: ATGE
Performance Overview: ATGE
Trailing total returns as of 6/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATGE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATGE
Valuation Measures
Market Cap
2.37B
Enterprise Value
3.03B
Trailing P/E
23.70
Forward P/E
10.68
PEG Ratio (5yr expected)
0.71
Price/Sales (ttm)
1.71
Price/Book (mrq)
1.79
Enterprise Value/Revenue
1.97
Enterprise Value/EBITDA
9.63
Financial Highlights
Profitability and Income Statement
Profit Margin
7.12%
Return on Assets (ttm)
5.52%
Return on Equity (ttm)
7.82%
Revenue (ttm)
1.54B
Net Income Avi to Common (ttm)
110.66M
Diluted EPS (ttm)
2.66
Balance Sheet and Cash Flow
Total Cash (mrq)
179.76M
Total Debt/Equity (mrq)
63.61%
Levered Free Cash Flow (ttm)
285.26M